During the ESMOImmuno25, we were able to present our AI multiomics and spatial immunology guided reverse translation for improving our understanding of colorectal cancer immunology and immunotherapy in patients as well as reveal our RETROFIT platform for next generation immunotherapy creation.
“ESMOImmuno25 last week was a fantastic experience!
Was an absolute pleasure to present our AI multiomics and spatial immunology guided reverse translation for improving our understanding of colorectal cancer immunology and immunotherapy in patients as well as reveal our RETROFIT platform for next generation immunotherapy creation together with PoC data of our first immunotherapy asset (RF-001) currently in preclinical validation stage to inhibit therapy refractory tumors!
Thanks for the invite and discussions: Niels Halama, Göran B Jönsson, Aurélien Marabelle, Sergio Quezada, Inge Marie Svane andfor the many fruitful interactions and discussions: Samra Turajlić, Thomas Gajewski, Rony Dahan, Drew Pardoll, Andreas Pircher, Steven O’Day, Hong I. Wan, Mark Cobbold, Daniela Thommen, Swethajit Biswas, Mark A. Exley, Evelien Smits and several others – was a truely memorable conference!”
